Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

GSK American Depositary Shares Representing 2 Ordinary Shares C.GSK


Primary Symbol: GSK

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed monoclonal antibodies to help treat different diseases. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes more than 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines include medicines for immune-mediated conditions. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases.


NYSE:GSK - Post by User

Post by Betteryear2on Mar 29, 2022 4:22pm
218 Views
Post# 34556732

Beschefer Central Drilling Visual Observations CSE:GSK

Beschefer Central Drilling Visual Observations CSE:GSK

Highlights:

  • Visual observations on approximately 1,245 metres of drilling completed across 5 holes

  • The targeted B14 gold-bearing shear zone has been intercepted in all holes drilled to date ranging from 12 to 31 metres in thickness

  • Initial assays have been delivered to the lab, with weekly batches expected over the remainder of the program

March 29, 2022 – TheNewswire - London, Ontario – Goldseek Resources Inc.(CSE:GSK)(FSE:4KG) (“Goldseek” or the “Company”) is pleased to announce an update from its 4,000-metre drill program currently underway at Beschefer, which kicked off in mid-February. The Company is finished drilling the Central Shallow & Deep Zones and is now drilling the East Zone. The Beschefer Project is located approximately 30 kilometres southwest of Wallbridge Mining Company Limited’s (“Wallbridge”) Fenelon Gold Project. On March 3rd, 2021, the Company entered into an option agreement on the Beschefer Project to earn 100% over 4 years from Wallbridge (see news release dated March 3, 2021).

https://www.thenewswire.com/press-releases/1LPRFojgQ-goldseek-announces-beschefer-central-drilling-visual-observations.html

 

 


<< Previous
Bullboard Posts
Next >>